2025 V-BID Advisory Board Meeting
On March 11, 2025, the V-BID Center Advisory Board convened for an engaging discussion with key stakeholders and sponsors.
Wednesday, Februrary 26, 2025: Value-Based Payment Summit Special Edition
On Wednesday, February 26, 2025, V-BID Center director, A. Mark Fendrick, spoke to attendees of the Value Based Payment Summit Special Edition. Dr. Fendrick's presented during the session, "Better Medicare Alliance Presents: The Role of Medicare Advantage in Meeting Beneficiary Needs." Associated resources are available below. Health Affairs Forefront Podcast Medicare Advantage 1-Pager Medicare Advantage White Paper Medicare Advantage Infographic Medicare Advantage Summary Medicare Advantage Brief Medicare Advantage Timeline
Tuesday, February 18, 2025: Lawrence General Hospital Grand Rounds
On Tuesday, February 18, 2025, V-BID Center director, A. Mark Fendrick, spoke at the Lawrence General Hospital Grand Rounds.
Wednesday, January 29, 2025: Primary Care Collaborative Webinar
On Wednesday, January 29, 2025, V-BID Center director, A. Mark Fendrick, spoke to participants of PCC's webinar on how anti-obesity GLP-1 treatments fit into a whole-person approach to primary care.
Virtual V-BID Summit 2025: 20 Years of Putting Patients First
On March 12, the 2025 V-BID Summit will bring together stakeholders from across the healthcare spectrum to discuss a number of timely topics.
Wednesday, January 8, 2025: University of Michigan IHPI National Clinical Scholars Program
On Wednesday, January 8, V-BID Center director, A. Mark Fendrick, presented to the IHPI National Clinical Scholars Program (NCSP).
Thursday, December 5, 2024: Xtalks Webinar – Navigating the Inflation Reduction Act
On December 5, 2024, V-BID Center Director, Dr. A. Mark Fendrick, spoke to attendees of the webinar, "Navigating the Inflation Reduction Act: Reassessing Evidence and Value Needs for Price Negotiations."
Tuesday, November 12, 2024: APG Fall Conference
On Tuesday, November 12, 2024, V-BID Center director, A. Mark Fendrick, spoke to participants of America's Physician Groups Fall Conference in Washington, DC.
Tuesday, November 5, 2024: University of Michigan HMP 660 Guest Lecture
On Tuesday, November 5, 2024, V-BID Center director, A. Mark Fendrick, presented to the students of University of Michigan School of Public Health HMP 660: Economics of Health Management and Policy.
Tuesday, October 15, 2024: University of Michigan Health System Science Branch Launch
On Tuesday, October 15, 2024, V-BID Center Director, Dr. A. Mark Fendrick, spoke at the University of Michigan Medical School M3 Branches Launch.
Tuesday, October 8, 2024: Health Management Associates National Conference
On Tuesday, October 8, 2024, V-BID Center director, A. Mark Fendrick, spoke to attendees of the HMA National Fall Conference in Chicago, IL. Dr. Fendrick's presentation was part of the panel, "Meeting Medicare's New Expectations for Health Equity and Improved Beneficiary Outcomes," which explored how CMS is adjusting Medicare Advantage rates and incentives to address equity gaps and improve outcomes, highlighting strategies for stakeholders to adapt to these changes.
Monday, September 16, 2024: Association for Community Affiliated Plans Pharmacy Roundtable
On Monday, September 16, 2024, V-BID Center director, A. Mark Fendrick, spoke to attendees of the Association for Community Affiliated Plans (ACAP) Pharmacy Roundtable.
Wednesday, September 11, 2024: Partnership to Fight Chronic Disease
On Wednesday, September 11, 2024, V-BID Center director, A. Mark Fendrick, took part in a discussion series hosted by the Partnership to Fight Chronic Disease.
Monday, September 9, 2024: COA Payer Exchange Summit
On Monday, September 9, 2024, V-BID Center director, A. Mark Fendrick, spoke at the Community Oncology Alliance (COA) Payer Exchange Summit.
Thursday, August 1, 2024: AHIP Chief Medical Officers Committee Meeting
On August 1, 2024, V-BID Center Director, Dr. A. Mark Fendrick, spoke at the AHIP Chief Medical Officers Committee meeting on unhealthy weight and access to anti-obesity medications.